FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Proposes Revised Procedures for New Labeling Info

[ Price : $8.95]

Federal Register Proposed rule: FDA proposes to revise procedures for approved drug or biological product holders to change labeli...

FDA OKs PresbiBio Phase 2 Trial of Microlens for Presbyopia

[ Price : $8.95]

FDA grants conditional approval to PresbiBio LLC for an IDE application to begin a Phase 2 trial of its Presbia Flexivue Microlens...

Depuy Agrees to $4 Billion Settlement on Defective Hip Devices

[ Price : $8.95]

Johnson & Johnsons device unit, Depuy, reportedly agrees to pay more than $4 billion to settle thousands of lawsuits over its reca...

FDA Continues Inspecting Hospira as Progress Ticks Along

[ Price : $8.95]

Troubled Hospira says it was recently inspected by FDA at its Lake Forest, IL and McPherson, KS facilities.

FDA Asks More Eloctate Manufacturing Process Info

[ Price : $8.95]

FDA asks Biogen Idec for additional process validation information for its blood clotting factor Eloctate.

CDRH Draft Guidance on Device Development Tools

[ Price : $8.95]

CDRH posts a draft guidance on Medical Device Development Tools that outlines a voluntary process for qualifying medical device de...

FDA Accepts sNDA for Bowel Drug Gattex

[ Price : $8.95]

FDA accepts for review an NPS Pharmaceuticals supplemental NDA for Gattex (teduglutide [rDNA origin]) for injection, which is curr...

FDA Asks OTC Topical Antiseptic Label, Packaging Changes

[ Price : $8.95]

FDA asks manufacturers of certain OTC topical antiseptics to revise the products labels and packaging to help prevent infections i...

FDA Grants Mast Therapeutics Orphan Status for MST-188

[ Price : $8.95]

FDA grants Mast Therapeutics an orphan drug designation for MST-188 for treating acute limb ischemia.

Reviewers Back Tasimelteon Approval

[ Price : $8.95]

CDER medical reviewers tell the Peripheral and Central Nervous System Advisory Committee that they recommend approval of Vanda Pha...